Home > Insider Trading > Filing (0001567619-19-008746)

Filing Details

Accession Number:: 0001567619-19-008746
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-04-12 15:28:15
Reporting Period:: 2019-03-05

Accepted Time:: 2019-04-12 15:28:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1128189	Protokinetix Inc.	PKTX	Pharmaceutical Preparations (2834)	943355026

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1516077	Edward Clarence Smith	1845 Country Road #214 St. Augustine FL 32084	President & Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-04-01	2,000,000	$0.05	61,353,833	No	4	P	Direct
Common Stock	Acquisiton	2019-03-05	50,000	$0.08	5,071,025	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-03-22	34,700	$0.06	5,105,725	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-03-26	5,300	$0.05	5,111,025	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-03-26	15,000	$0.07	5,126,025	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-03-26	20,000	$0.06	5,146,025	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-03-27	15,000	$0.07	5,161,025	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-03-28	18,700	$0.07	5,179,725	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-03-28	100,000	$0.08	5,279,725	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-03-29	60,000	$0.08	5,339,725	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-04-01	21,300	$0.07	5,361,025	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-04-01	50,000	$0.08	5,411,025	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-04-02	12,000	$0.07	5,423,025	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-04-02	20,000	$0.07	5,443,025	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-04-03	10,000	$0.08	5,453,025	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-04-04	10,000	$0.08	5,463,025	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-04-05	60,000	$0.06	5,523,025	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-04-08	146,667	$0.06	5,669,692	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-04-09	10,000	$0.07	5,679,692	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-04-09	152,000	$0.07	5,831,692	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-04-10	94,242	$0.07	5,925,934	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-04-10	66,667	$0.07	5,992,601	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-04-11	9,000	$0.06	6,001,601	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-04-11	19,000	$0.07	6,020,601	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-04-15	10,000	$0.06	6,030,601	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-04-15	5,000	$0.07	6,035,601	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-04-15	38,000	$0.07	6,073,601	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,850,000	Indirect	See footnote

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option	$0.09	2023-11-08	5,000,000	5,000,000	Direct
Common Stock	Stock Option	$0.06	2021-08-31	5,000,000	5,000,000	Direct
Common Stock	Stock Option	$0.05	2020-12-31	5,000,000	5,000,000	Direct
Common Stock	Stock Option	$0.08	2019-12-31	5,000,000	5,000,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2023-11-08	5,000,000	5,000,000	Direct
2021-08-31	5,000,000	5,000,000	Direct
2020-12-31	5,000,000	5,000,000	Direct
2019-12-31	5,000,000	5,000,000	Direct

Footnotes

Shares purchased by Mr. Smith from the Company in a private placement.
Shares held by the Clarence E. Smith Trust and purchased on the open market.
Shares held by Mr. Smith's retirement account.
Options granted pursuant to Amended 2017 Stock Option and Stock Bonus Plan. On March 31, 2019, 1,250,000 shares vest; thereafter 1,250,000 shares vest each quarter.
Options granted pursuant to 2017 Stock Option and Stock Bonus Plan. On December 31, 2017, 1,250,000 shares vested; thereafter 1,250,000 shares vested each quarter.
Options granted pursuant to 2017 Stock Option and Stock Bonus Plan. On March 31, 2017, 1,250,000 shares vested; thereafter 1,250,000 shares vested each quarter.
Options granted pursuant to 2015 Stock Option and Stock Bonus Plan. On March 31, 2016, 1,250,000 shares vested; thereafter 1,250